Planning an upcoming vaccine trial? Let’s discuss how Finland could support it.

‍

Clinical trials | Pragmatic trials | Register-based RWE

Meet our team at World Vaccine Congress Europe to discuss your upcoming trial and how FVR’s vaccine-specific expertise, clinic network and Finland’s unique RWE register infrastructure could support your evidence needs.

Why FVR?

Eight specialised vaccine research clinics under one agreement
Decades of vaccine-specific clinical expertise
Strong recruitment and retention capabilities
Pragmatic trial and register-based RWE expertise
Finland’s exceptional opportunities for long-term register-based follow-up

Request a meeting at World Vaccine Congress Europe - we’ll get back to you to confirm.

Thank you! Your request has been received!

Oops! Something went wrong while submitting the form.

Make sure not to miss these:

‍

Clinical Trials – Track 3, Wednesday 21 October at 10:30
“FinDementia – A Pragmatic Phase 4 Trial Designed to Demonstrate Effectiveness of Recombinant Shingles Vaccine Against Dementia” /Arto Palmu, Chief Scientific Officer

Scientific poster, main poster area
"FVR - Finnish Vaccine Research: Upscaling Vaccine Trial Recruitment Through Digital Transformation" /Marissa Gripenberg, Senior R&D Specialist

Jenni Vuola

Chief Executive Officer

Arto Palmu

Chief Scientific Officer

Santtu Heinonen

Lead Medical Expert

Marissa Gripenberg

Senior R&D Specialist

Ilona Schmidt

Head of Customer Relations